Diagnostic performance of the QuantiFERON-TB Gold In-Tube assay and factors associated with nonpositive results in patients with miliary tuberculosis
- PMID: 24457341
- DOI: 10.1093/cid/ciu045
Diagnostic performance of the QuantiFERON-TB Gold In-Tube assay and factors associated with nonpositive results in patients with miliary tuberculosis
Abstract
The QuantiFERON-TB Gold In-Tube (QFT-GIT) assay provides suboptimal diagnostic performance in patients with miliary tuberculosis. QFT-GIT results should be carefully interpreted, particularly in patients suspected of having miliary tuberculosis with severe lymphocytopenia or an extent of ground glass opacity (GGO) >50% on chest computed tomography (CT). Diagnostic performance of the QFT-GIT assay was evaluated in 44 patients with miliary tuberculosis. Among these individuals, 30 (68%) had true-positive QFT-GIT results. Severe lymphocytopenia and an extent of GGO >50% on chest CT were independent risk factors for nonpositive QFT-GIT results.
Keywords: QuantiFERON-TB Gold In-Tube assay; interferon-gamma release assay; miliary tuberculosis.
Comment in
-
Reply to Hong et al.Clin Infect Dis. 2014 Jul 1;59(1):142-3. doi: 10.1093/cid/ciu249. Epub 2014 Apr 11. Clin Infect Dis. 2014. PMID: 24729495 Free PMC article. No abstract available.
-
Is the sensitivity of the QuantiFERON-TB gold in-tube test lower than that of T-SPOT.TB in patients with miliary tuberculosis?Clin Infect Dis. 2014 Jul 1;59(1):142. doi: 10.1093/cid/ciu248. Epub 2014 Apr 11. Clin Infect Dis. 2014. PMID: 24729500 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources